id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-N-3656-0002,FDA,FDA-2025-N-3656,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practices for Positron Emission Tomography Drugs,Notice,30 Day Proposed Information Collection,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-01-29T04:59:59Z,2026-01-31T13:12:34Z,2025-23859,0,0,09000064b910a46c
FDA-2025-N-3656-0001,FDA,FDA-2025-N-3656,Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practices for Positron Emission Tomography Drugs,Notice,60 Day Proposed Information Collection,2025-09-25T04:00:00Z,2025,9,2025-09-25T04:00:00Z,2025-11-25T04:59:59Z,2025-09-25T18:47:07Z,2025-18620,0,0,09000064b8fdc124